Approved Use: Aimovig™ is a prescription medicine used for the preventive treatment of migraine in adults.

Important Safety Information

Before starting Aimovig™, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your healthcare provider or pharmacist about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig™?

The most common side effects of Aimovig™ are pain, redness, or swelling at the injection site and constipation.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of Aimovig™. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Click here for Full Prescribing Information and Patient Product Information.

Approved Use

Aimovig™ is a prescription medicine used for the preventive treatment of migraine in adults.

your access to Aimovig

get Aimovig today at your favorite pharmacy*

introducing two offers in one convenient card

for eligible commercially insured patients

access card access card

$5 copay per month

or

if your insurance does not cover Aimovig
or a PA is required

Aimovig at no cost for up to 12 doses while coverage is pursued

activate your card

Program details:

With the Aimovig Ally Access Card, an eligible commercially insured patient can receive one of the following two offers:

  • If approved by the patient’s health plan to take Aimovig (erenumab‐aooe), a patient pays a $5 copay per month, up to a maximum benefit of $2700 annually. This applies to patient out‐of pocket costs, including deductible, co‐insurance, and copayments for Aimovig™. Patient is responsible for costs above the annual maximum. See full Terms and Conditions below.
  • If the patient’s health plan does not cover Aimovig or requires a prior authorization, the patient can qualify for the Bridge to Commercial Coverage offer and receive Aimovig™ at no cost for up to 12 doses, while pursuing approval from their health plan. See full Terms and Conditions below.

Terms and Conditions for Copay Offer: Pay a $5 copay per month, up to a maximum benefit of $2700 annually. Patient must be prescribed Aimovig™. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is receiving prescription reimbursement under any federal‐, state‐, or government funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. If at any time patient begins receiving coverage under any such federal‐, state‐, or government‐funded healthcare program, patient will no longer be able to use this offer and patient must call 833‐AIMOVIG to stop participation. Patient may not seek reimbursement for value received from this offer from any third‐party payers, including flexible spending accounts or healthcare savings accounts. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice. This is not health insurance. If you become aware that your health plan or pharmacy benefit manager does not allow the use of manufacturer copay support as part of your health plan design, you agree to comply with your obligations, if any, to disclose your use of the card to your insurer. This offer is ongoing and in order to remain eligible, patient must re‐enroll every 12 months by visiting www.aimovigaccesscard.com/ or by calling 833‐AIMOVIG (833‐246‐6844).

Terms and Conditions for Bridge to Commercial Coverage Offer: Aimovig at no cost for up to 12 doses while insurance coverage is pursued. Patient must be prescribed Aimovig and have previously failed another preventive migraine treatment. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is receiving prescription reimbursement under any federal‐, state‐,or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. If at any time patient begins receiving coverage under any such federal‐, state‐, or government‐funded healthcare program, patient will no longer be able to use this offer and patient must call 833‐AIMOVIG to stop participation. Once insurance approval is obtained, patient is no longer eligible for this offer. Ongoing eligibility (http://www.aimovigaccesscard.com/ongoingeligibility) is subject to demonstrated efforts to pursue commercial coverage. No purchase necessary. This is not health insurance. Participation is not a guarantee of insurance coverage. Patient may be required to re‐enroll. This offer is not renewable. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice.

Ongoing eligibility for Bridge to Commercial Coverage Offer (Aimovig at no cost for up to 12 doses) Eligible patient must have commercial prescription insurance, a valid prescription for Aimovig, previously failed another preventive migraine treatment, and participate in an insurance plan that requires a prior authorization or does not provide coverage for Aimovig. Bridge to Commercial Coverage Offer provides up to 12 doses to patient while insurance coverage is pursued for up to 24 months from enrollment, whichever occurs first. Once insurance approval is obtained, patient is no longer eligible for the offer. Offer is not renewable. By participating in this offer, patient acknowledges intent to pursue insurance coverage for Aimovig with their healthcare provider. Ongoing eligibility requires that patient has (i) a prior authorization or medical exception denied within 90 days of first use of offer, and (ii) an appeal of the prior authorization or medical exception denied within 180 days of first use of offer. See full Terms and Conditions for more information.

once you have activated your card

once you have activated your access card, please print out and bring your enrollment confirmation page with you to your pharmacist. The enrollment confirmation contains important patient and pharmacist instructions, and includes the following information:

  • BIN and PCN numbers
  • Program Instructions
  • Your group and member ID

*Copay Offer and Bridge to Commercial Coverage Offer fulfillment dependent on pharmacy election to process Aimovig Ally access card based on program terms and conditions. Aimovig Ally cannot guarantee fulfillment by any particular pharmacy.

Patients will be eligible to participate in one or the other offer depending on whether their health plan covers Aimovig and/or requires a prior authorization. For eligible patients with commercial insurance approved by their health plan to take Aimovig , the Aimovig Copay Offer can help reduce prescription costs to no more than $5 per month up to a $2,700 annual cap.
Eligibility criteria and program limits apply.

Aimovig Ally support

Our support team is your ally. We're here to help you get started by answering questions and providing resources.

  • We offer supplemental injection support including live video chats
  • Supplemental in-home injection support when requested by your doctor
  • Call us at 833-AIMOVIG (833-246-6844), Monday-Friday, 8 am-8 pm ET
  • Sign up for helpful resources and educational materials today
contact us here 1-833-AIMOVIG (1-833-246-6844)
8 AM-8 PM ET, Mon-Fri

Important Safety Information

Before starting Aimovig™, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your healthcare provider or pharmacist about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig™?

The most common side effects of Aimovig™ are pain, redness, or swelling at the injection site and constipation.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of Aimovig™. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Click here for Full Prescribing Information and Patient Product Information.

Approved Use

Aimovig™ is a prescription medicine used for the preventive treatment of migraine in adults.